Skip to main content
Log in

Acute Intrathecal Baclofen Withdrawal: A Brief Review of Treatment Options

  • Practical Pearl
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Acute baclofen toxicity and withdrawal can present with a constellation of symptoms making differentiation between these two entities and other potential diagnoses challenging. Baclofen withdrawal is associated with numerous complications which may require neurocritical care expertise such as respiratory failure, refractory seizures, delirium, and blood pressure lability.

Methods

Case report and literature review.

Results

This case report discusses a case of intrathecal baclofen (ITB) withdrawal, focusing on the differential diagnosis for acute baclofen withdrawal and reviews the various options that exist to treat the symptoms of acute baclofen withdrawal such as benzodiazepines, propofol, skeletal muscle relaxants, and tizanidine.

Conclusions

Critical care practitioners should be prepared to treat this potentially devastating and often refractory complication of ITB therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Coffey RJ, Edgar TS, Francisco GE, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil. 2002;83:735–41.

    Article  PubMed  Google Scholar 

  2. Dawes WJ, Drake JM, Fehlings D. Microfracture of a baclofen pump catheter with intermittent under- and overdose. Pediatr Neurosurg. 2003;39:144–8.

    Article  PubMed  Google Scholar 

  3. Leo RJ, Baer D. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics. 2005;46:503–7.

    Article  CAS  PubMed  Google Scholar 

  4. Lyew MA, Mondy C, Eagle S, Chernich SE. Hemodynamic instability and delayed emergence from general anesthesia associated with inadvertent intrathecal baclofen overdose. Anesthesiology. 2003;98:265–8.

    Article  PubMed  Google Scholar 

  5. Coffey JR, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993;78:226–32.

    Article  CAS  PubMed  Google Scholar 

  6. Kao LW, Amin Y, Kirk MA, Turner MS. Intrathecal baclofen withdrawal mimicking sepsis. J Emerg Med. 2003;24:423–7.

    Article  PubMed  Google Scholar 

  7. Korenkov AI, Niendorf WR, Darwish N, Glaeser E, Gaab MR. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries. Neurosurgery. 2002;25:228–30.

    Google Scholar 

  8. Douglas AF, Weiner HL, Schwartz DR. Prolonged intrathecal baclofen withdrawal syndrome. Case report and discussion of current therapeutic management. J Neurosurg. 2005;102:1133–6.

    Article  PubMed  Google Scholar 

  9. Meythaler JM, Roper JF, Brunner RC. Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil. 2003;84:638–42.

    Article  PubMed  Google Scholar 

  10. Salazar ML, Eiland LS. Intrathecal baclofen withdrawal resembling serotonin syndrome in an adolescent boy with cerebral palsy. Pediatr Emerg Care. 2008;24:691–3.

    Article  PubMed  Google Scholar 

  11. Khorasani A, Peruzzi WT. Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesth Analg. 1995;80:1054–6.

    Article  CAS  PubMed  Google Scholar 

  12. Samson-Fang L, Gooch J, Norlin C. Intrathecal baclofen withdrawal simulating neuroepileptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol. 2000;42:561–5.

    Article  CAS  PubMed  Google Scholar 

  13. Turner MR, Gainsborough N. Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen. J Psychopharmacol (Oxf). 2001;15:61–3.

    Article  CAS  Google Scholar 

  14. Kroin JS, Bianchi GD, Penn RD. Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa. J Neurosurg. 1993;79:544–9.

    Article  CAS  PubMed  Google Scholar 

  15. Greenberg MI, Hendrickson RG. Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement. J Toxicol Clin Toxicol. 2003;41:83–5.

    Article  PubMed  Google Scholar 

  16. Package insert. Lioresal intrathecal (baclofen injection). Minneapolis: Medtronic, Inc.; 2002.

  17. Bellinger A, Siriwetchadarak R, Rosenquist R, Greenlee JD. Prevention of intrathecal baclofen withdrawal syndrome: successful use of a temporary intrathecal catheter. Reg Anesth Pain Med. 2009;34:600–2.

    Article  PubMed  Google Scholar 

  18. Saveika JA, Shelton JE. Cyproheptadine for pediatric intrathecal baclofen withdrawal: a case report. Am J Phys Med Rehabil. 2007;86:994–7.

    Article  PubMed  Google Scholar 

  19. Cruikshank M, Eunson P. Intravenous diazepam infusion in the management of planned intrathecal baclofen withdrawal. Dev Med Child Neurol. 2007;49:626–8.

    Article  PubMed  Google Scholar 

  20. Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome—a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol. 2004;4:1–5.

    Article  Google Scholar 

  21. Ackland GL, Fox R. Low-dose propofol infusion for controlling acute hyperspasticity after withdrawal of intrathecal baclofen therapy. Anesthesiology. 2005;103:663–5.

    Article  PubMed  Google Scholar 

  22. Reeves RK, Stolp-Smith KA, Christopherson MW. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch Phys Med Rehabil. 1998;79:353–6.

    Article  CAS  PubMed  Google Scholar 

  23. Shimizu M, Yamakura T, Tobita T, et al. Propofol enhances GABA(A) receptor-mediated presynaptic inhibition in human spinal cord. Neuroreport. 2002;13:357–60.

    Article  CAS  PubMed  Google Scholar 

  24. Hansen CR, Gooch JL, Such-Neibar T. Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report. Arch Phys Med Rehabil. 2007;88:1468–71.

    Article  PubMed  Google Scholar 

  25. Amann BL, Pogarell O, Mergl R, et al. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol. 2003;18:641–6.

    Article  CAS  PubMed  Google Scholar 

  26. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301:489–99.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aaron M. Cook.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, J.C., Cook, A.M., Stewart, G.L. et al. Acute Intrathecal Baclofen Withdrawal: A Brief Review of Treatment Options. Neurocrit Care 14, 103–108 (2011). https://doi.org/10.1007/s12028-010-9422-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-010-9422-6

Keywords

Navigation